Evidence map›Paper›PMID 35349315›Full record

ArticleAmerican journal of public health2022

Drug Overdose Epidemic Colliding With COVID-19: What the United States Can Learn From France.

Max Jordan Nguemeni Tiako, Jules Netherland, Helena Hansen, Marie Jauffret-Roustide

Abstract readEditorial
In one paragraph

Article in American journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Prescription opioids and economic hardship in France.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Max Jordan Nguemeni TiakoMax Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue.
Jules NetherlandMax Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue.
Helena HansenMax Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue.
Marie Jauffret-RoustideMax Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue.

Funding

Mainstreaming Opioid Maintenance Treatment into General Medicine: Effects on AddiK01DA032674 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HANSEN, HELENA BJERRING · 2012 to 2016
$903k
NIDA NIH HHS K01 DA032674
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Drug OverdoseEpidemicsFranceHumansUnited States

Identifiers

PMID35349315
PMCPMC8965177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.